Danish Medicines Agency
Reports summarize new developments from Danish Medicines Agency
Published in Healthcare Finance, Tax and Law Weekly, August 15th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Danish Medicines Agency.
Report 1: An article published in the New England Journal of Medicine (NEJM) has raised concern about a small increased risk of myocardial infarction and cardiovascular death in patients with type 2 diabetes treated with rosiglitazone. The article, based on an analysis of data retrieved from 42 clinical studies, showed a small increased risk for myocardial infarction and cardiovascular death among approximately 15,500 patients treated with rosiglitazone...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Abbey Spanier Rodd & Abrams, Llp
Abbey Spanier Rodd & Abrams, LLP Announces Class Action Securities Fraud Suit on Behalf of Health Management Associates, Inc. Investors - Abbott
The Princeton Review Names Abbott One of the 'Best Companies for Entry-Level Jobs' - Aging
National Conference on Medical, Legal and Ethical Issues of Eldercare - Amira Pharmaceuticals
Amira Pharmaceuticals Announces Appointment of First Chief Executive Officer - Angiology
Fujitsu and BizTech Healthcare Solutions Protect Patients From Identity Theft and Insurance Fraud - Angiotech Pharmaceuticals, Inc.
Angiotech appoints Laura Brege to its Board of Directors - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
